Patent ductus arteriosus (PDA) device closure was first attempted by Porstmann et al. in 1967 (
1). In recent years, percutaneous transcatheter closure of PDA has been a widely used treatment method. For the percutaneous transcatheter closure of the symptomatic PDA, Amplatzer duct occluders (ADOs) are commonly used (
2). In neonates or patients with specific PDA morphology, PDA device closure has been difficult due to the device protrusion into the thoracic aorta (
3-
8). The right angle between the plug and disc causes the protrusion of the disc into the thoracic aorta because most PDA cases have an acute angle with the thoracic aorta. Therefore, clinical trials using modified or angled ADOs were reported (
9,
10). These reports quoted from Mancini’s postmortem study in 1951 that resulted in an acute angle formed by PDA with the descending thoracic aorta of average 31.8° (
11).